Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VBI-1901 |
| Trade Name | |
| Synonyms | VBI1901|VBI 1901 |
| Drug Descriptions |
VBI-1901 is a vaccine comprising enveloped virus-like particles that contain GM-CSF linked to the cytomegalovirus antigens, glycoprotein B (gB) and phosphoprotein 65 (pp65), thereby potentially stimulating an immune attack against gB and pp65-expressing cancer cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C143956 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Sargramostim + VBI-1901 | Sargramostim VBI-1901 | 0 | 0 |
| VBI-1901 | VBI-1901 | 0 | 1 |